Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1996 AL 2010

Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity

Pyun JM, Ryu JS, Lee R, Shim KH, Youn YC, Ryoo N, Han SW, Park YH, Kang S, An SSA, Kim S.

Clin Interv Aging. 2021 Apr 30;16:749-755. doi: 10.2147/CIA.S312473. eCollection 2021.

Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences

Erickson CM, Chin NA, Coughlin DM, Conway CE, Rosario HL, Johnson SC, Clark LR.

J Am Geriatr Soc. 2021 Jul;69(7):2044-2047. doi: 10.1111/jgs.17184. Epub 2021 May 7.

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population

Gleerup HS, Jensen CS, Høgh P, Hasselbalch SG, Simonsen AH.

EBioMedicine. 2021 May;67:103361. doi: 10.1016/j.ebiom.2021.103361. Epub 2021 May 8.

Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis

Ge YJ, Xu W, Ou YN, Qu Y, Ma YH, Huang YY, Shen XN, Chen SD, Tan L, Zhao QH, Yu JT.

Ageing Res Rev. 2021 Aug;69:101361. doi: 10.1016/j.arr.2021.101361. Epub 2021 May 14.

Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease

Alawode DOT, Heslegrave AJ, Ashton NJ, Karikari TK, Simrén J, Montoliu-Gaya L, Pannee J, O Connor A, Weston PSJ, Lantero-Rodriguez J, Keshavan A, Snellman A, Gobom J, Paterson RW, Schott JM, Blennow K, Fox NC, Zetterberg H.

J Intern Med. 2021 Sep;290(3):583-601. doi: 10.1111/joim.13332. Epub 2021 Jun 26.

TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample

Rodrigo-Herrero S, Luque-Tirado A, Méndez-Barrio C, García-Solís D, Bernal Sánchez-Arjona M, Oropesa-Ruiz JM, Maillet D, Franco-Macías E.

J Alzheimers Dis. 2021;82(1):401-410. doi: 10.3233/JAD-210115.

State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer's disease

Hampel H, Shaw LM, Aisen P, Chen C, Lleó A, Iwatsubo T, Iwata A, Yamada M, Ikeuchi T, Jia J, Wang H, Teunissen CE, Peskind E, Blennow K, Cummings J, Vergallo A.

Alzheimers Dement. 2022 Jan;18(1):159-177. doi: 10.1002/alz.12372. Epub 2021 May 27.

Benson's Disease or Posterior Cortical Atrophy, Revisited

Yerstein O, Parand L, Liang LJ, Isaac A, Mendez MF.

J Alzheimers Dis. 2021;82(2):493-502. doi: 10.3233/JAD-210368.

Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in Sydney

Sexton CE, Anstey KJ, Baldacci F, Barnum CJ, Barron AM, Blennow K, Brodaty H, Burnham S, Elahi FM, Götz J, Jeon YH, Koronyo-Hamaoui M, Landau SM, Lautenschlager NT, Laws SM, Lipnicki DM, Lu H, Masters CL, Moyle W, Nakamura A, Pasinetti GM, Rao N, Rowe C, Sachdev PS, Schofield PR, Sigurdsson EM, Smith K, Srikanth V, Szoeke C, Tansey MG, Whitmer R, Wilcock D, Wong TY, Bain LJ, Carrillo MC.

Alzheimers Dement. 2022 Jan;18(1):178-190. doi: 10.1002/alz.12380. Epub 2021 May 31.

Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care

Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, Tomic S, Nobili F, Frederiksen KS; Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel.

J Alzheimers Dis. 2021;82(3):883-898. doi: 10.3233/JAD-210335.

Editorial: Designing a Protocol Adopting an Artificial Intelligence (AI)-Driven Approach for Early Diagnosis of Late-Onset Alzheimer's Disease

Li VOK, Lam JCK, Han Y, Cheung LYL, Downey J, Kaistha T, Gozes I.

J Mol Neurosci. 2021 Jul;71(7):1329-1337. doi: 10.1007/s12031-021-01865-z.

Retinal imaging in Alzheimer's disease

Cheung CY, Mok V, Foster PJ, Trucco E, Chen C, Wong TY.

J Neurol Neurosurg Psychiatry. 2021 Sep;92(9):983-994. doi: 10.1136/jnnp-2020-325347. Epub 2021 Jun 9.

Lithium: A therapeutic option in Alzheimer's disease and its prodromal stages?

Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M.

Neurosci Lett. 2021 Aug 24;760:136044. doi: 10.1016/j.neulet.2021.136044. Epub 2021 Jun 10.

Anosognosia in dementia with Lewy bodies: a systematic review

Calil V, Sudo FK, Santiago-Bravo G, Lima MA, Mattos P.

Arq Neuropsiquiatr. 2021 Apr;79(4):334-342. doi: 10.1590/0004-282X-ANP-2020-0247.

Contribution of Gut Microbiota to Immunological Changes in Alzheimer's Disease

van Olst L, Roks SJM, Kamermans A, Verhaar BJH, van der Geest AM, Muller M, van der Flier WM, de Vries HE.

Front Immunol. 2021 May 31;12:683068. doi: 10.3389/fimmu.2021.683068. eCollection 2021.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias